You just read:

European Commission Ratifies Positive CHMP Opinion for the Renewal of Translarna™ Marketing Authorization for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy

News provided by

PTC Therapeutics, Inc.

Jan 09, 2017, 17:48 ET